Transmembrane TNF- : structure, function and interaction with anti-TNF agents

Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor

(2009) Zehra Kaymakcalan et al.   CLINICAL IMMUNOLOGY

Differences in binding and effector functions between classes of TNF antagonists

(2009) Taruna Arora et al.   CYTOKINE

Anti-TNF immunotherapy reduces CD8+ T cell–mediated antimicrobial activity against Mycobacterium tuberculosis in humans

(2009) Heiko Bruns et al.   JOURNAL OF CLINICAL INVESTIGATION

Lipid rafts uncouple surface expression of transmembrane TNF-α from its cytotoxicity associated with ICAM-1 clustering in Raji cells

(2009) Shu Zhang et al.   MOLECULAR IMMUNOLOGY

Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab

(2008) Hiroki Mitoma et al.   ARTHRITIS AND RHEUMATISM

Influence of reverse signaling via membrane TNF-α on cytotoxicity of NK92 cells

(2008) Mingxia Yu et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced byLeishmania major infection

(2008) Cindy Allenbach et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Tumour necrosis factor antagonists: structure, function, and tuberculosis risks

(2008) Robert S Wallis   LANCET INFECTIOUS DISEASES

A Systematic Review of the Off-Label Use of Biological Therapies in Systemic Autoimmune Diseases

(2008) Manuel Ramos-Casals et al.   MEDICINE

TNF-mediated inflammatory disease

(2007) JR Bradley   JOURNAL OF PATHOLOGY

Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

(2007) Daniel Tracey et al.   PHARMACOLOGY & THERAPEUTICS